rs878854398
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001848.3(COL6A1):c.1425delA(p.Gly476AlafsTer29) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,612,612 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001848.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- collagen 6-related myopathyInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
- Bethlem myopathy 1AInheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
- Ullrich congenital muscular dystrophy 1AInheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL6A1 | NM_001848.3 | c.1425delA | p.Gly476AlafsTer29 | frameshift_variant | Exon 21 of 35 | ENST00000361866.8 | NP_001839.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151768Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250728 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1460844Hom.: 0 Cov.: 37 AF XY: 0.0000138 AC XY: 10AN XY: 726768 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151768Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74096 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
Identified in a heterozygous state in a patient with metabolic myopathy and reported as a variant of uncertain significance (PMID: 27854218); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30564623, 27854218) -
COL6A1-related disorder Pathogenic:1
The COL6A1 c.1425delA variant is predicted to result in a frameshift and premature protein termination (p.Gly476Alafs*29). This variant was reported in an individual with phenotypes suggestive of a metabolic myopathy (Punetha et al. 2016. PubMed ID: 27854218). This variant is reported in 0.0016% of alleles in individuals of European (non-Finnish) descent in gnomAD. Frameshift variants in COL6A1 are expected to be pathogenic. This variant is interpreted as likely pathogenic for autosomal recessive COL6A1-related disorders. -
Bethlem myopathy 1A Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly476Alafs*29) in the COL6A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL6A1 are known to be pathogenic (PMID: 19884007, 20976770). This variant is present in population databases (rs781122262, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with metabolic myopathy (PMID: 27854218). ClinVar contains an entry for this variant (Variation ID: 224705). For these reasons, this variant has been classified as Pathogenic. -
not specified Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at